Financial statements Invest Pharmaceuticals
Cash inflows of INVEST PHARMACEUTICALS
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 10 860 123,38 | 8 414 537,86 | 2 883 603,04 | 4 134 376,58 | -14 136 583,68 | -927 930,44 |
| Net cash flow from investing activities | 123 465,07 | 74 172,72 | -6 469 800,15 | -175 504,43 | -9 826,37 | 35 788,32 |
| Net cash flow from financial activities | -11 785 099,14 | -8 562 436,45 | 6 558 909,91 | -5 198 255,05 | 12 028 601,84 | 624 710,82 |
| Total net cash flow | -801 510,69 | -73 725,87 | 2 972 712,80 | -1 239 382,90 | -2 117 808,21 | -267 431,30 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.